457949-09-6

Basic information

• Product Name: Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)
• Synonyms: Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI);6,7-Dihydroimidazo[1,2-a]pyridin-8(5H)-one;2-Hydroxy-6-methyl-1,2,3,4-tetrahydroquinoline-4-carboxylic acid
• CAS NO: 457949-09-6
• Molecular Formula: C7H8N2O
• Molecular Weight: 136.15122
• Product Categories: AMINETERTIARY
• Mol File: 457949-09-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 314.4±25.0 °C(Predicted)
• Appearance: /
• Density: 1.35±0.1 g/cm3(Predicted)
• PKA: 4.03±0.20(Predicted)
• CAS DataBase Reference: Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)(457949-09-6)
• EPA Substance Registry System: Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI)(457949-09-6)

Safety Data

• Hazardous Substances Data: 457949-09-6(Hazardous Substances Data)

Usage

General Description

Imidazo[1,2-a]pyridin-8(5H)-one, 6,7-dihydro- (9CI) is a chemical compound with a molecular formula C8H7N3O. It belongs to the class of imidazo[1,2-a]pyridine compounds and is also known as PHA-250280. This chemical has potential pharmaceutical applications, particularly in the field of drug discovery and development. It is being studied for its potential as an anti-cancer and anti-inflammatory agent. Additionally, it may have uses in the treatment of neurological disorders and other medical conditions. Further research and development are ongoing to explore the full potential of this compound for therapeutic purposes.

Upstream product

• 24016-03-3 2-amino-3-benzyloxypyridine 
• 16867-03-1 2-amino-3-hydroxypyridine 
• 96428-16-9 8-(phenylmethoxy)imidazo[1,2-a]pyridine 
• 156817-68-4 hydroxy-8 tetrahydro-5,6,7,8 imidazo<1,2-a>pyridine 
• 457949-10-9 C₇H₉ClN₂O 

Relevant articles and documents

Bisheterocycle substituted oxa-spiro derivative, and preparation method and medical application thereof

The invention relates to a bisheterocyclic substituted oxa-spiro derivative, and a preparation method and medical application thereof. Specifically, the invention discloses compounds of formula (I) and formula (II) or pharmaceutically acceptable salts, stereoisomers or solvates thereof, and a preparation method and application thereof. Each group in the formulas is as defined in the specificationand claims in detail.

NITROGEN-CONTAINING HETEROARYL COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY

A compound of the formula (I): wherein Z4, Z5 and Z9 each is independently carbon atom or nitrogen atom; Y is hydroxy, mercapto or amino; RA is a group of the formula: (wherein C ring is nitrogen-containing heteroaryl) has an inhibitory activity against integrase.